• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

Recent Advances in the Study of 2-nitro-N-propylbenzene-1-sulfonamide (CAS: 89840-63-1): A Comprehensive Research Brief

2-nitro-N-propylbenzene-1-sulfonamide (CAS: 89840-63-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This sulfonamide derivative, characterized by its nitro and propyl functional groups, has been the subject of several studies aimed at exploring its biological activity, synthetic pathways, and pharmacological potential. The compound's molecular structure, which combines a benzene ring with a sulfonamide moiety, makes it a promising candidate for further investigation in drug discovery and development.

Recent studies have focused on the synthesis and optimization of 2-nitro-N-propylbenzene-1-sulfonamide, with particular emphasis on improving its yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and ensure its structural integrity. Researchers have also investigated the compound's stability under various conditions, revealing insights into its degradation pathways and potential storage requirements. These findings are critical for ensuring the compound's suitability for further preclinical and clinical studies.

In addition to its synthetic aspects, the biological activity of 2-nitro-N-propylbenzene-1-sulfonamide has been a key area of research. Preliminary in vitro studies have demonstrated its potential as an antimicrobial agent, with notable activity against a range of Gram-positive and Gram-negative bacteria. The compound's mechanism of action appears to involve inhibition of bacterial cell wall synthesis, although further studies are needed to elucidate the precise molecular targets. Moreover, its low cytotoxicity in mammalian cell lines suggests a favorable safety profile, making it a promising lead compound for the development of new antibiotics.

Beyond its antimicrobial properties, 2-nitro-N-propylbenzene-1-sulfonamide has also shown potential in other therapeutic areas. Recent research has explored its anti-inflammatory and anticancer activities, with encouraging results in preclinical models. For instance, the compound has been found to inhibit the production of pro-inflammatory cytokines in macrophages, suggesting its potential utility in treating inflammatory diseases. Similarly, its ability to induce apoptosis in certain cancer cell lines highlights its potential as an anticancer agent. These findings underscore the versatility of 2-nitro-N-propylbenzene-1-sulfonamide and its potential applications across multiple therapeutic domains.

Despite these promising developments, several challenges remain in the study of 2-nitro-N-propylbenzene-1-sulfonamide. Issues such as its solubility, bioavailability, and metabolic stability need to be addressed to facilitate its transition from the laboratory to clinical applications. Future research directions may include the development of prodrugs or formulation strategies to enhance its pharmacokinetic properties. Additionally, further mechanistic studies are required to fully understand its biological effects and optimize its therapeutic potential.

In conclusion, 2-nitro-N-propylbenzene-1-sulfonamide (CAS: 89840-63-1) represents a compound of significant interest in the field of chemical biology and pharmaceutical research. Its unique structural features, combined with its diverse biological activities, make it a promising candidate for further investigation. Continued research efforts aimed at optimizing its synthesis, elucidating its mechanisms of action, and improving its pharmacological properties will be essential for unlocking its full therapeutic potential. This research brief highlights the current state of knowledge on this compound and underscores the need for further studies to fully realize its applications in medicine.

• 832730-54-8(Benzenesulfonamide, N,N'-1,5-pentanediylbis[2-nitro-)
• 89840-65-3(Benzenesulfonamide,N-(2-methylpropyl)-2-nitro-)
• 89840-66-4(Benzenesulfonamide, N-(1-methylpropyl)-2-nitro-)
• 437718-20-2(Benzenesulfonamide,N-(5-aminopentyl)-2-nitro-, hydrochloride (1:1))
• 240423-09-0(Benzenesulfonamide,N-(3-aminopropyl)-2-nitro-)
• 89840-64-2(N-Butyl-2-Nitrobenzenesulfonamide)
• 83019-91-4(N-(2-aminoethyl)-2-nitrobenzene-1-sulfonamide)
• 211512-13-9(N-(4-Aminobutyl)-2-nitrobenzenesulfonamide)
• 89840-68-6(Benzenesulfonamide, 2-nitro-N-octyl-)
• 89840-67-5(Benzenesulfonamide, N-hexyl-2-nitro-)